All lobbying filings

The KPM Group DC LLC

The KPM Group DC LLC filed a Q1 report for Mahzi Therapeutics on April 20, 2026, reporting $20,000 in lobbying income.

Lobbying for Mahzi Therapeutics · Focused on treating under‐served rare genetic neurodevelopmental disorders

As filed: THE KPM GROUP DC LLC for MAHZI THERAPEUTICS.

All filings by The KPM Group DC LLC · Everything Mahzi Therapeutics has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Medical/Disease Research/Clinical Labs

Priority review voucher (PRV) re-authorization, ICD-10 codes

Health Issues

Priority review voucher (PRV) re-authorization, ICD-10 codes

Science/Technology

Priority review voucher (PRV) re-authorization, ICD-10 codes

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.